SENS Note - 26 March 2013
Ciplamed final results 31 December 2012

Revenue for the year ended 31 December 2012 shot up to R2.3 billion (2011: R1.8 billion). Gross profit rose to R1.1 billion (2011: R1 billion), but total comprehensive income attributable to equity holders of the parent fell to R161.4 million (2011: R233.9 million). Furthermore, headline earnings per share dropped to 37.6cps (2011: 55.3cps).

Dividend
No final dividend will be declared for the 2012 year as a result of the Cipla India transaction.

Subsequent events
During February 2013, as mentioned above, Cipla India made a firm intention offer for the acquisition of 100% of the share capital of CMSA. This did not impact the group's results for the year ended 31 December 2012. Other than the event referred to above, the directors are not aware of any other matter or circumstance which is material to the financial affairs of the group, which has occurred subsequent to 31 December 2012, that has not been otherwise dealt with in the consolidated financial results.

Click here for original article
distributed by